MOUNJARO KWIKPEN DIN 02551977
Health Canada record
| Active ingredient(s) | TIRZEPATIDE 7.5 MG |
|---|---|
| Dosage form | Solution |
| Route | Subcutaneous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | A10BX16 TIRZEPATIDE |
| Original market date | 10-Dec-2024 |
| Current status date | 10-Dec-2024 |
| Source | Health Canada DPD |
Establishment licence of the holder
Eli Lilly Canada Inc. — licence 100164, currently licensed, last inspection rating C (2026-03-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TIRZEPATIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02532891 | MOUNJARO | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 2.5 MG | Approved |
| 02532905 | MOUNJARO | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 5 MG | Approved |
| 02532913 | MOUNJARO | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 7.5 MG | Approved |
| 02532921 | MOUNJARO | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 10 MG | Approved |
| 02532948 | MOUNJARO | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 12.5 MG | Approved |
| 02532956 | MOUNJARO | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 15 MG | Approved |
| 02541041 | MOUNJARO | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 2.5 MG | Marketed |
| 02541068 | MOUNJARO | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 5 MG | Marketed |
| 02541076 | MOUNJARO | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 7.5 MG | Marketed |
| 02541084 | MOUNJARO | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 10 MG | Marketed |
| 02541092 | MOUNJARO | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 12.5 MG | Marketed |
| 02541106 | MOUNJARO | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 15 MG | Marketed |
| 02551950 | MOUNJARO KWIKPEN | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 2.5 MG | Marketed |
| 02551969 | MOUNJARO KWIKPEN | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 5 MG | Marketed |
| 02551985 | MOUNJARO KWIKPEN | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 10 MG | Marketed |
| 02551993 | MOUNJARO KWIKPEN | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 12.5 MG | Marketed |
| 02552000 | MOUNJARO KWIKPEN | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 15 MG | Marketed |
| 02557509 | ZEPBOUND | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 2.5 MG | Marketed |
| 02557517 | ZEPBOUND | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 5 MG | Marketed |
| 02557525 | ZEPBOUND | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 7.5 MG | Marketed |
| 02557533 | ZEPBOUND | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 10 MG | Marketed |
| 02557541 | ZEPBOUND | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 12.5 MG | Marketed |
| 02557568 | ZEPBOUND | ELI LILLY CANADA INC | Solution | TIRZEPATIDE 15 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 34078 | 2024-09-24 | Supplement to a New Drug Submission (SNDS) | Addition of new dosage form: Addition of a preserved formulation in a multi-dose prefilled pen. Addition of a drug product manufacturing site and /or manufacturer involving production. New package labels |
International API supply for TIRZEPATIDE
40 active FDA Drug Master Files.
Request a quote for MOUNJARO KWIKPEN